NCT01943994 - Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 1, 2023

Study Completion Date

November 14, 2023

Conditions

Nicotine Dependence

Interventions

DRUG

Psilocybin-assisted treatment

Participants will be administered 30 mg/70 kg psilocybin. Preliminary evidence from our ongoing psilocybin dose-effects study suggests that this dose is associated with mystical-type experiences.

DRUG

Nicotine Replacement Therapy (NRT)

Trial Locations (2)

21224

Behavioral Pharmacology Research Unit, Baltimore

Neuroimaging Research Branch, NIDA-IRP, Baltimore